Vasiliki Xirou, MD

INPATIENT THROMBOCYTOPENIA One of the more straightforward consults is the inpatient with de novo thrombocytopenia. Why? Because the VAST majority of cases are due to infection or medications. Those that are not can make things interesting!

Is precision medicine accurate medicine?

Bursting with pride as my first friend of internship @PeterNatov presents his outstanding heart failure research at Medical Grand Rounds this AM…we’re going to miss this guy next year! @YaleIMed @YaleCardiology @MarkDSiegel1 @TuftsMCCVFellow

.@RimmPathology is presenting on “Precision Medicine vs. Persuasion Medicine: Measuring vs. Reading HER2” at @YaleCancer Grand Rounds. @YaleMed #breastcancer #pathology #CancerResearch

So excited to be part of #ESMOYOC committee! Many thanks to @amanda_psyrri @AKyriazoglou @PGrivasMDPhD @RimmPathology @AttikonUniHosp @HeSMOtweet @GR_WomenSTEM @WomeninOnc

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study - Annals of Oncology annalsofoncology.org/article/S0923-…

Very excited to share my first first-author work!🫀 Improved renal function (ie, decreasing Cr) when treating AHF is paradoxically associated w/ increased mortality, driven not by renal tubular injury, instead by greater congestion & more underlying cardiorenal disease.

👉Wonderful talk by Dr @amanda_psyrri , Co-chair of #ESMOImmuno22 providing an overview of Lessons learned from trials of systemic immunotherapies in r/m HNSCC

How AI and deep learning can advance clinical practice and research in the field of Ophthalmology. I am so thrilled to be a part of this amazing symposium hosted by @FutureVisionOrg @NEIDirector @USCEye @KeckMedUSC

Always fantastic to see awesome trainees in Greece with great potential! Proud of @mkmoutafi #ElinaVlachou & great to see both at #PROSCA22 in Athens!They have done a great job at @Yale & @hopkinskimmel respectively! @JCensits @NazliDizman @DMakrakisMD @LDiamantMD @DRBakaloudiMD

Streamlining clinical research: An ESMO awareness call to improve Sponsoring and Monitoring of Clinical Trials. annalsofoncology.org/article/S0923-…

@AileenIlianaPhD @fredhutch @DocBLord @ZegarraRuizPhD @MariangeBravo @jayeperview @AlexJaraCarta @aaronlavelmoye Congratulations Aileen!

Back on the east coast after an incredible visit to @fredhutch for the #MendezSymposium. I am in awe to have been selected among these incredible scientists and DEI leaders!

Last Saturday, I finished 100 miles for the @CTFRide in recognition of the amazing oncologists, researchers, and nurses @SmilowCancer and @YaleCancer. Thanks to all who donated and congrats to the many riders out there. What an amazing event and a beautiful ride in souther CT!

.@mkmoutafi and @RimmPathology will present a poster on #PARP inhibitor treatment for head and neck squamous cell carcinoma today, 9/10 at 8:16am EST/2:16pm CEST at #ESMO22 @myESMO @SmilowCancer @YaleMed @YNHH @yalepathology

New #JITC article: Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer bit.ly/3Cq8hHv @mkmoutafi @DrRoyHerbstYale @RimmPathology @jon_zuga

Excited to share our work 👇 !!!

On Sept 10, I will cycle 100 miles for the @CTFRide! This event raises money for cancer research @SmilowCancer & @YaleCancer. Please consider donating to my ride to recognize the amazing researchers, oncologists, & nurses caring for patients at Smilow!🚴‍♂️ rideclosertofree.org/participant/26…

First up, Dr. Sofia Athanasopoulou! Sofia grew up and attended medical school in Athens, Greece. She then moved to Oxford, England, where she started off her career as a junior doctor before deciding to continue her training in the US. 1/4 @sgathanas

.@RimmPathology of @YalePathology will present at #WCLC22 @IASLC in Vienna, Austria on, “Discovery of Predictive Biomarkers for Immunotherapy Using Deep Spatial Tissue Analysis in Lung Cancer.” @YaleMed @YaleCancer bit.ly/3Q1mMFG